Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q3 2025

Type / Class
Equity / Common stock, par value $ 0.000001 per share
Symbol
TIL on Nasdaq
Shares outstanding
6,505,400
Price per share
$10.96
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,655,269
Total reported value
$47,423,593
% of total 13F portfolios
0%
Share change
-96,374
Value change
-$2,963,439
Number of holders
33
Price from insider filings
$10.96
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vivo Capital IX, LLC 4.5% $7,169,276 292,743 Vivo Capital IX, LLC 30 Jun 2025

As of 30 Sep 2025, 33 institutional investors reported holding 2,655,269 shares of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL). This represents 41% of the company’s total 6,505,400 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) together control 41% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BML Capital Management, LLC 9.9% 645,600 +21% 11% $11,530,416
CPMG Inc 6.3% 410,922 0% 36% $7,339,067
Vivo Capital, LLC 4.5% 292,743 0% 0.42% $5,228,390
Siren, L.L.C. 3.1% 203,933 0% 0.14% $3,642,243
MILLENNIUM MANAGEMENT LLC 3% 196,742 +82% 0% $3,513,812
VANGUARD GROUP INC 2.6% 167,810 -0.17% 0% $2,997,087
SECTORAL ASSET MANAGEMENT INC 2.5% 161,380 +87% 1.8% $2,882,247
MORGAN STANLEY 1.6% 102,938 +6.9% 0% $1,838,472
DIMENSIONAL FUND ADVISORS LP 1.2% 80,816 -2.4% 0% $1,443,653
BlackRock, Inc. 0.95% 61,682 +22% 0% $1,101,640
Boxer Capital Management, LLC 0.93% 60,700 -14% 0.35% $1,084,102
MACQUARIE GROUP LTD 0.77% 50,000 0% 0% $893,000
MARSHALL WACE, LLP 0.69% 44,878 0% $801,522
GEODE CAPITAL MANAGEMENT, LLC 0.65% 42,339 -1.8% 0% $756,489
LPL Financial LLC 0.52% 33,687 0% $601,650
JANE STREET GROUP, LLC 0.32% 20,802 0% $371,524
STATE STREET CORP 0.27% 17,595 0% 0% $314,247
NORTHERN TRUST CORP 0.24% 15,684 -76% 0% $280,116
AlphaQuest LLC 0.23% 14,747 +85% 0.02% $263,381
Americana Partners, LLC 0.16% 10,676 -17% 0.01% $190,673
BARCLAYS PLC 0.09% 6,150 -41% 0% $109,839
UBS Group AG 0.09% 5,621 -65% 0% $100,391
Tower Research Capital LLC (TRC) 0.05% 3,134 +1358% 0% $55,973
BNP PARIBAS FINANCIAL MARKETS 0.05% 3,104 0% 0% $55,437
BANK OF AMERICA CORP /DE/ 0.01% 599 -42% 0% $10,698

Institutional Holders of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 2,655,269 $47,423,593 -$2,963,439 $17.86 33
2025 Q2 2,751,266 $57,311,087 -$11,020,093 $20.83 37
2025 Q1 3,353,462 $58,216,200 -$97,479 $17.36 42
2024 Q4 3,339,375 $63,749,218 -$66,077,020 $19.09 39
2024 Q3 3,419,403 $230,187,844 +$81,138,546 $67.32 48
2024 Q2 2,328,646 $23,960,769 -$220,805 $10.29 29
2024 Q1 2,348,572 $25,363,318 +$3,416,073 $10.80 30
2023 Q4 2,037,306 $15,523,621 +$13,556,922 $7.62 27